| scholarly article | Q13442814 |
| P2093 | author name string | ALSUntangled Group | |
| P2860 | cites work | A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 |
| Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants | Q28373006 | ||
| Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation | Q28373562 | ||
| Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis | Q28486263 | ||
| Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease. | Q34075502 | ||
| Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'. | Q34330984 | ||
| Tauroursodeoxycholic acid prevents amyloid-beta peptide-induced neuronal death via a phosphatidylinositol 3-kinase-dependent signaling pathway | Q34520873 | ||
| Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats | Q35022852 | ||
| Oral solubilized ursodeoxycholic acid therapy in amyotrophic lateral sclerosis: a randomized cross-over trial | Q35730907 | ||
| Ursodeoxycholic acid prevents apoptosis of mouse sensory neurons induced by cisplatin by reducing P53 accumulation | Q39971872 | ||
| Antibacterial and anti-atrophic effects of a highly soluble, acid stable UDCA formula in Helicobacter pylori-induced gastritis | Q39988461 | ||
| Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages | Q42254171 | ||
| Safety, tolerability, and cerebrospinal fluid penetration of ursodeoxycholic Acid in patients with amyotrophic lateral sclerosis. | Q43236433 | ||
| Tauroursodeoxycholic acid partially prevents apoptosis induced by 3-nitropropionic acid: evidence for a mitochondrial pathway independent of the permeability transition | Q43509966 | ||
| Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes | Q43933924 | ||
| Neuroprotection by a bile acid in an acute stroke model in the rat. | Q43937496 | ||
| Antioxidant properties of ursodeoxycholic acid. | Q44214673 | ||
| Tauroursodeoxycholic acid and secondary damage after spinal cord injury in rats | Q46700273 | ||
| Progression in ALS is not linear but is curvilinear. | Q51691332 | ||
| P433 | issue | 5-6 | |
| P304 | page(s) | 475-478 | |
| P577 | publication date | 2014-06-27 | |
| P1433 | published in | Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration | Q23928840 |
| P1476 | title | ALSUntangled no. 25: ursodiol | |
| P478 | volume | 15 |
| Q60920623 | Method development and validation of ursodiol and its major metabolites in human plasma by HPLC-tandem mass spectrometry | cites work | P2860 |
Search more.